CN105814192A - 哺乳动物视网膜干细胞产生方法和应用 - Google Patents

哺乳动物视网膜干细胞产生方法和应用 Download PDF

Info

Publication number
CN105814192A
CN105814192A CN201480066229.3A CN201480066229A CN105814192A CN 105814192 A CN105814192 A CN 105814192A CN 201480066229 A CN201480066229 A CN 201480066229A CN 105814192 A CN105814192 A CN 105814192A
Authority
CN
China
Prior art keywords
isolated
alk
signaling
retinal
stem cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480066229.3A
Other languages
English (en)
Chinese (zh)
Inventor
K·张
J·赵
艾达·阿勒穆泰里
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California, San Diego
Original Assignee
University of California, San Diego
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, San Diego filed Critical University of California, San Diego
Priority to CN202610489182.6A priority Critical patent/CN122465845A/zh
Publication of CN105814192A publication Critical patent/CN105814192A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/062—Sensory transducers, e.g. photoreceptors; Sensory neurons, e.g. for hearing, taste, smell, pH, touch, temperature, pain
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/165—Vascular endothelial growth factor [VEGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/395—Thyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/42—Notch; Delta; Jagged; Serrate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases [EC 2.]
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
CN201480066229.3A 2013-10-09 2014-10-09 哺乳动物视网膜干细胞产生方法和应用 Pending CN105814192A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202610489182.6A CN122465845A (zh) 2013-10-09 2014-10-09 哺乳动物视网膜干细胞产生方法和应用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361888846P 2013-10-09 2013-10-09
US61/888,846 2013-10-09
PCT/US2014/059951 WO2015054526A2 (en) 2013-10-09 2014-10-09 Methods of mammalian retinal stem cell production and applications

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202610489182.6A Division CN122465845A (zh) 2013-10-09 2014-10-09 哺乳动物视网膜干细胞产生方法和应用

Publications (1)

Publication Number Publication Date
CN105814192A true CN105814192A (zh) 2016-07-27

Family

ID=52813744

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201480066229.3A Pending CN105814192A (zh) 2013-10-09 2014-10-09 哺乳动物视网膜干细胞产生方法和应用
CN202610489182.6A Pending CN122465845A (zh) 2013-10-09 2014-10-09 哺乳动物视网膜干细胞产生方法和应用

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202610489182.6A Pending CN122465845A (zh) 2013-10-09 2014-10-09 哺乳动物视网膜干细胞产生方法和应用

Country Status (5)

Country Link
US (1) US10220117B2 (cg-RX-API-DMAC7.html)
EP (1) EP3047017B1 (cg-RX-API-DMAC7.html)
JP (1) JP6651440B2 (cg-RX-API-DMAC7.html)
CN (2) CN105814192A (cg-RX-API-DMAC7.html)
WO (1) WO2015054526A2 (cg-RX-API-DMAC7.html)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106754718A (zh) * 2016-12-19 2017-05-31 胡其锐 一种人胚胎干细胞快速定向分化至视网膜色素上皮细胞的方法
CN109312306A (zh) * 2016-04-22 2019-02-05 大日本住友制药株式会社 产生视网膜组织的方法
CN110573607A (zh) * 2016-11-16 2019-12-13 洋蓟治疗有限公司 多能干细胞测定
CN111065731A (zh) * 2017-06-16 2020-04-24 Imba-莫利库尔生物技术研究所 血管类器官、产生和使用所述类器官的方法
CN112334574A (zh) * 2018-06-20 2021-02-05 拜奥拉米那公司 用于产生视网膜色素上皮细胞的方法和组合物
CN113272422A (zh) * 2018-09-07 2021-08-17 赫贝细胞股份有限公司 用于无载体3d球体悬浮培养中视网膜神经元生成的方法和组合物
US11214771B2 (en) 2014-10-24 2022-01-04 Sumitomo Dainippon Pharma Co., Ltd. Production method for nerve tissue
WO2023011251A1 (zh) * 2021-08-05 2023-02-09 呈诺再生医学科技(珠海横琴新区)有限公司 快速高效的临床级色素上皮细胞诱导方法、试剂盒及应用
CN116445409A (zh) * 2023-06-16 2023-07-18 中国人民解放军总医院第三医学中心 视杆感光前体细胞的制备方法及其应用
WO2023177181A1 (ko) * 2022-03-14 2023-09-21 주식회사 스페이스에프 돼지 만능성 줄기세포 배양용 배지 조성물
CN116948970A (zh) * 2023-08-21 2023-10-27 昆明理工大学 一种能够高效的获得足够数量的、高纯度人cr神经元的培养基、方法及其应用
EP4522186A4 (en) * 2022-05-11 2026-06-10 Scherer Technologies Llc R P METHOD FOR DIFFERENTIATING MULTIPOTENTED STEM CELLS INTO RETINAL PIGMENTED EPITHELIAL CELLS

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2684460C (en) * 2007-04-18 2017-01-03 Hadasit Medical Research Services & Development Limited Stem cell-derived retinal pigment epithelial cells
US8642334B2 (en) 2009-02-17 2014-02-04 Memorial Sloan Kettering Cancer Center Methods of neural conversion of human embryonic stem cells
AU2012332269B2 (en) 2011-11-04 2018-05-31 Memorial Sloan-Kettering Cancer Center Midbrain dopamine (DA) neurons for engraftment
JP6756610B2 (ja) 2013-04-26 2020-09-16 メモリアル スローン ケタリング キャンサー センター 多分化能細胞および多能性細胞の分化を方向付けることによって発生させる皮質介在ニューロンおよびその他のニューロン細胞
AU2015336454B2 (en) 2014-10-24 2021-04-29 Racthera Co., Ltd. Production method for retinal tissue
JP6824526B2 (ja) * 2015-04-14 2021-02-03 国立大学法人京都大学 大脳皮質ニューロンの誘導方法
US11332717B2 (en) 2015-07-22 2022-05-17 The Johns Hopkins University Three-dimensional vascular network assembly from induced pluripotent stem cells
CN114807035B (zh) 2015-09-08 2024-02-02 (由卫生与公众服务部部长代表的)美利坚合众国 临床级别视网膜色素上皮细胞的可再现的分化方法
AU2016320991C1 (en) 2015-09-08 2023-04-06 Healios K.K. Method for producing retinal pigment epithelial cells
US11162070B2 (en) 2015-09-08 2021-11-02 FUJIFILM Cellular Dynamics, Inc. MACS-based purification of stem cell-derived retinal pigment epithelium
WO2017070333A1 (en) 2015-10-20 2017-04-27 Cellular Dynamics International, Inc. Multi-lineage hematopoietic precursor cell production by genetic programming
CN106609255B (zh) * 2015-10-22 2019-11-05 同济大学 含pj34和视网膜色素上皮细胞的细胞悬液及其应用
CN105274049B (zh) * 2015-11-03 2018-01-09 中山大学中山眼科中心 一种诱导人iPSc源性的3D视网膜定向分化为视网膜神经节细胞的方法
EP3384008A4 (en) * 2015-12-04 2019-10-02 Bond University Ltd Methods of differentiating retinal cells
US11781110B2 (en) * 2016-04-29 2023-10-10 The Regents Of The University Of California Induction of corneal endothelial cells
WO2018146679A2 (en) * 2017-02-08 2018-08-16 Hadasit Medical Research Services And Development Ltd. Photoreceptor cells for the treatment of retinal diseases
US11618883B2 (en) 2017-03-08 2023-04-04 Sumitomo Pharma Co., Ltd. Method for producing retinal pigment epithelial cells
CN110891967B (zh) 2017-04-18 2025-03-14 富士胶片细胞动力公司 抗原特异性免疫效应细胞
CN107326009B (zh) * 2017-05-02 2019-03-08 深圳百年干细胞技术研究院有限公司 使血液单个核细胞逆向分化产生人血源性自体视网膜干细胞的方法、试剂盒及用途
US11168301B2 (en) 2017-10-05 2021-11-09 Eyestem Research Private Limited Method for producing photoreceptor cells, retinal pigmented epithelial cells, and retinal organoids
US12497591B2 (en) 2018-03-07 2025-12-16 Sorbonne Universite Compositions and methods for efficient amplification of retinal progenitors cells
WO2019204817A1 (en) 2018-04-20 2019-10-24 FUJIFILM Cellular Dynamics, Inc. Method for differentiation of ocular cells and use thereof
TWI675678B (zh) * 2018-08-23 2019-11-01 國為生醫科技股份有限公司 亞丁基苯酞於多巴胺神經前驅細胞移植治療的應用
AU2019336540B2 (en) * 2018-09-09 2025-02-13 Qanatpharma Ag Use of casein kinase 1 inhibitors for treating vascular diseases
WO2020090705A1 (ja) 2018-10-31 2020-05-07 千寿製薬株式会社 網膜神経節細胞死抑制剤
GB201913196D0 (en) * 2019-09-12 2019-10-30 Univ Newcastle Culture method
WO2022138803A1 (ja) * 2020-12-24 2022-06-30 国立研究開発法人理化学研究所 視細胞を含む層状の網膜組織の促成製造方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080089868A1 (en) * 2006-04-27 2008-04-17 The Research Foundation Of State University Of New York Retinal stem cell compositions and methods for preparing and using same
US20100105137A1 (en) * 2007-01-18 2010-04-29 Riken Method for induction/differentiation into photoreceptor cell
WO2012158910A2 (en) * 2011-05-18 2012-11-22 The Regents Of The University Of California Compositions and methods for treating retinal diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632679B2 (en) 2002-07-16 2009-12-15 The Trustees Of Columbia University In The City Of New York Systems and methods for screening for modulators of neural differentiation
US7541186B2 (en) 2006-02-22 2009-06-02 University Of Washington Method of generating human retinal progenitors from embryonic stem cells
KR100846506B1 (ko) 2006-12-19 2008-07-17 삼성전자주식회사 Pn 다이오드를 포함하는 상변화 메모리 소자와 그 제조및 동작 방법
US8642334B2 (en) * 2009-02-17 2014-02-04 Memorial Sloan Kettering Cancer Center Methods of neural conversion of human embryonic stem cells
EP2464723B1 (en) 2009-08-12 2016-06-22 Kyoto University Method for inducing differentiation of pluripotent stem cells into neural precursor cells
JP5985208B2 (ja) * 2011-11-25 2016-09-06 住友化学株式会社 網膜組織の製造方法
JP6468843B2 (ja) 2012-02-17 2019-02-13 ザ スキーペンズ アイ リサーチ インスティチュート ヒト網膜前駆細胞の表現型プロファイル

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080089868A1 (en) * 2006-04-27 2008-04-17 The Research Foundation Of State University Of New York Retinal stem cell compositions and methods for preparing and using same
US20100105137A1 (en) * 2007-01-18 2010-04-29 Riken Method for induction/differentiation into photoreceptor cell
WO2012158910A2 (en) * 2011-05-18 2012-11-22 The Regents Of The University Of California Compositions and methods for treating retinal diseases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BAOZHI CHEN等: "Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer", 《NAT CHEM BIOL.》 *

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12492373B2 (en) 2014-10-24 2025-12-09 Racthera Co., Ltd. Production method for nerve tissue
US11214771B2 (en) 2014-10-24 2022-01-04 Sumitomo Dainippon Pharma Co., Ltd. Production method for nerve tissue
CN109312306A (zh) * 2016-04-22 2019-02-05 大日本住友制药株式会社 产生视网膜组织的方法
US11371016B2 (en) 2016-04-22 2022-06-28 Sumitomo Pharma Co., Ltd. Method for producing retinal tissue
CN110573607B (zh) * 2016-11-16 2023-10-20 洋蓟治疗有限公司 多能干细胞测定
CN110573607A (zh) * 2016-11-16 2019-12-13 洋蓟治疗有限公司 多能干细胞测定
CN106754718A (zh) * 2016-12-19 2017-05-31 胡其锐 一种人胚胎干细胞快速定向分化至视网膜色素上皮细胞的方法
CN111065731A (zh) * 2017-06-16 2020-04-24 Imba-莫利库尔生物技术研究所 血管类器官、产生和使用所述类器官的方法
CN111065731B (zh) * 2017-06-16 2024-03-12 Imba-莫利库尔生物技术研究所 血管类器官、产生和使用所述类器官的方法
CN112334574A (zh) * 2018-06-20 2021-02-05 拜奥拉米那公司 用于产生视网膜色素上皮细胞的方法和组合物
CN113272422A (zh) * 2018-09-07 2021-08-17 赫贝细胞股份有限公司 用于无载体3d球体悬浮培养中视网膜神经元生成的方法和组合物
WO2023011251A1 (zh) * 2021-08-05 2023-02-09 呈诺再生医学科技(珠海横琴新区)有限公司 快速高效的临床级色素上皮细胞诱导方法、试剂盒及应用
WO2023177181A1 (ko) * 2022-03-14 2023-09-21 주식회사 스페이스에프 돼지 만능성 줄기세포 배양용 배지 조성물
EP4522186A4 (en) * 2022-05-11 2026-06-10 Scherer Technologies Llc R P METHOD FOR DIFFERENTIATING MULTIPOTENTED STEM CELLS INTO RETINAL PIGMENTED EPITHELIAL CELLS
CN116445409B (zh) * 2023-06-16 2023-09-22 中国人民解放军总医院第三医学中心 视杆感光前体细胞的制备方法及其应用
CN116445409A (zh) * 2023-06-16 2023-07-18 中国人民解放军总医院第三医学中心 视杆感光前体细胞的制备方法及其应用
CN116948970A (zh) * 2023-08-21 2023-10-27 昆明理工大学 一种能够高效的获得足够数量的、高纯度人cr神经元的培养基、方法及其应用

Also Published As

Publication number Publication date
JP2016537967A (ja) 2016-12-08
WO2015054526A3 (en) 2015-06-04
EP3047017A2 (en) 2016-07-27
JP6651440B2 (ja) 2020-02-19
EP3047017B1 (en) 2025-09-10
EP3047017A4 (en) 2017-10-11
WO2015054526A2 (en) 2015-04-16
US10220117B2 (en) 2019-03-05
EP3047017C0 (en) 2025-09-10
US20160243285A1 (en) 2016-08-25
CN122465845A (zh) 2026-07-28

Similar Documents

Publication Publication Date Title
US10220117B2 (en) Methods of mammalian retinal stem cell production and applications
US9359592B2 (en) Method for differentiation into retinal cells from stem cells
KR102527507B1 (ko) 만능 줄기 세포로부터 제조된 광수용기 및 광수용기 전구체
KR102625865B1 (ko) 만능 세포를 분화시키는 방법
US9200252B2 (en) Compositions for inducing differentiation into retinal cells from retinal progenitor cells or inducing proliferation of retinal cells comprising Wnt signaling pathway activators
JP7793137B2 (ja) 背側化シグナル伝達物質又は腹側化シグナル伝達物質による錐体視細胞又は桿体視細胞の増加方法
JP2023182584A (ja) 網膜組織の製造方法
WO2016063985A1 (ja) 神経組織の製造方法
CN110684734A (zh) 用于植入的中脑多巴胺(da)神经元
JP2016537967A5 (cg-RX-API-DMAC7.html)
JP2019506901A (ja) ヒト人工多能性幹細胞からの皮質ニューロンの分化
CN112601814A (zh) 包含嗅神经细胞或其前体细胞的细胞团块及其制备方法
JP7859632B2 (ja) 視細胞を含む層状の網膜組織の促成製造方法
CN113272422A (zh) 用于无载体3d球体悬浮培养中视网膜神经元生成的方法和组合物
WO2017126551A1 (ja) ヒト多能性幹細胞から視床下部ニューロンへの分化誘導
WO2013131012A1 (en) Isolation and use of pluripotent stem cell population from adult neural crest-derived tissues
WO2023054396A1 (ja) 下垂体組織を含む細胞集団の製造方法及びその細胞集団
WO2022239868A1 (ja) 網膜組織の製造方法
JP2024520424A (ja) 黄斑、中心および末梢網膜色素上皮細胞を生成する方法
US20220259558A1 (en) Methods for obtaining eye field progenitor cells from human pluripotent stem cells
HK40059700B (zh) 神经组织的制备方法
Corti Uncoupling tumorigenicity from dopaminergic differentiation potential of hiPSCs by acting on Glypican4: combining in vitro differentiation studies with preclinical studies for Parkinson's Disease therapy
CN121420058A (zh) 增强神经祖细胞的神经元分化
HK40029697A (en) Method for amplifying cone photoreceptors or rod photoreceptors using dorsalization signal transmitter or ventralization signal transmitter
HK40029200A (en) Method for producing retinal tissues

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination